Omega Healthcare Investors (NYSE:OHI) Posts Earnings Results, Beats Expectations By $0.33 EPS

Omega Healthcare Investors (NYSE:OHI) issued its earnings results on Wednesday. The real estate investment trust reported $0.74 EPS for the quarter, topping the consensus estimate of $0.41 by $0.33, Zacks reports. Omega Healthcare Investors had a return on equity of 8.83% and a net margin of 34.41%. Omega Healthcare Investors updated its FY 2025 guidance to 2.900-2.980 EPS.

Omega Healthcare Investors Stock Down 0.3 %

Omega Healthcare Investors stock traded down $0.13 during midday trading on Friday, hitting $37.93. 913,437 shares of the company’s stock were exchanged, compared to its average volume of 1,883,250. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The firm has a 50-day moving average of $38.06 and a two-hundred day moving average of $39.06. Omega Healthcare Investors has a 12 month low of $29.17 and a 12 month high of $44.42. The company has a market cap of $10.24 billion, a PE ratio of 27.87, a P/E/G ratio of 1.08 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.07%. The ex-dividend date of this dividend is Monday, February 10th. Omega Healthcare Investors’s payout ratio is presently 197.06%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on OHI. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Mizuho boosted their price objective on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a research note on Thursday, December 5th. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a research note on Monday, December 9th. JMP Securities reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a research report on Friday. Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research note on Thursday, October 31st. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $41.67.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.